A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination

NCT02606877 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: nintedanib
DRUG: pirfenidone

Sponsor

Boehringer Ingelheim